CN103284926A - Cypress essential oil bath salt - Google Patents
Cypress essential oil bath salt Download PDFInfo
- Publication number
- CN103284926A CN103284926A CN201310229539XA CN201310229539A CN103284926A CN 103284926 A CN103284926 A CN 103284926A CN 201310229539X A CN201310229539X A CN 201310229539XA CN 201310229539 A CN201310229539 A CN 201310229539A CN 103284926 A CN103284926 A CN 103284926A
- Authority
- CN
- China
- Prior art keywords
- sodium
- bath salt
- oil bath
- quintessence oil
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000019341 magnesium sulphate Nutrition 0.000 title claims abstract description 27
- CSNNHWWHGAXBCP-UHFFFAOYSA-L magnesium sulphate Substances [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 title claims abstract description 26
- 241000218691 Cupressaceae Species 0.000 title claims abstract description 25
- 239000000341 volatile oil Substances 0.000 title abstract description 4
- 235000002639 sodium chloride Nutrition 0.000 claims abstract description 16
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims abstract description 15
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims abstract description 11
- 239000011734 sodium Substances 0.000 claims abstract description 11
- 229910052708 sodium Inorganic materials 0.000 claims abstract description 11
- 229920001202 Inulin Polymers 0.000 claims abstract description 9
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims abstract description 9
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims abstract description 9
- 229940029339 inulin Drugs 0.000 claims abstract description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000004166 Lanolin Substances 0.000 claims abstract description 8
- 229940039717 lanolin Drugs 0.000 claims abstract description 8
- 235000019388 lanolin Nutrition 0.000 claims abstract description 8
- 239000011780 sodium chloride Substances 0.000 claims abstract description 8
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 claims description 19
- KAZSKMJFUPEHHW-DHZHZOJOSA-N Licochalcone A Chemical compound COC1=CC(O)=C(C(C)(C)C=C)C=C1\C=C\C(=O)C1=CC=C(O)C=C1 KAZSKMJFUPEHHW-DHZHZOJOSA-N 0.000 claims description 10
- KAZSKMJFUPEHHW-UHFFFAOYSA-N (2E)-3-[5-(1,1-dimethyl-2-propenyl)-4-hydroxy-2-methoxyphenyl]-1-(4-hdyroxyphenyl)-2-propen-1-one Natural products COC1=CC(O)=C(C(C)(C)C=C)C=C1C=CC(=O)C1=CC=C(O)C=C1 KAZSKMJFUPEHHW-UHFFFAOYSA-N 0.000 claims description 9
- IUCVKTHEUWACFB-UHFFFAOYSA-N Licochalcone A Natural products COC1=CC=C(C(C)(C)C=C)C=C1C=CC(=O)C1=CC=C(O)C=C1 IUCVKTHEUWACFB-UHFFFAOYSA-N 0.000 claims description 9
- AFHJQYHRLPMKHU-OSYMLPPYSA-N aloin A Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1[C@@H]1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 AFHJQYHRLPMKHU-OSYMLPPYSA-N 0.000 claims description 9
- 229960000271 arbutin Drugs 0.000 claims description 9
- CCCMONHAUSKTEQ-UHFFFAOYSA-N octadecene Natural products CCCCCCCCCCCCCCCCC=C CCCMONHAUSKTEQ-UHFFFAOYSA-N 0.000 claims description 9
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 claims description 9
- 230000002087 whitening effect Effects 0.000 claims description 9
- AFHJQYHRLPMKHU-XXWVOBANSA-N Aloin Natural products O=C1c2c(O)cc(CO)cc2[C@H]([C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O2)c2c1c(O)ccc2 AFHJQYHRLPMKHU-XXWVOBANSA-N 0.000 claims description 8
- AFHJQYHRLPMKHU-UHFFFAOYSA-N isobarbaloin Natural products OC1C(O)C(O)C(CO)OC1C1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 AFHJQYHRLPMKHU-UHFFFAOYSA-N 0.000 claims description 8
- 150000003839 salts Chemical class 0.000 claims description 8
- 239000003795 chemical substances by application Substances 0.000 claims description 7
- 229920000570 polyether Polymers 0.000 claims description 7
- RRLOOYQHUHGIRJ-UHFFFAOYSA-M sodium;ethyl sulfate Chemical compound [Na+].CCOS([O-])(=O)=O RRLOOYQHUHGIRJ-UHFFFAOYSA-M 0.000 claims description 6
- BDJRBEYXGGNYIS-UHFFFAOYSA-N nonanedioic acid Chemical compound OC(=O)CCCCCCCC(O)=O BDJRBEYXGGNYIS-UHFFFAOYSA-N 0.000 claims description 4
- VGEREEWJJVICBM-UHFFFAOYSA-N phloretin Chemical compound C1=CC(O)=CC=C1CCC(=O)C1=C(O)C=C(O)C=C1O VGEREEWJJVICBM-UHFFFAOYSA-N 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 3
- ZWTDXYUDJYDHJR-UHFFFAOYSA-N (E)-1-(2,4-dihydroxyphenyl)-3-(2,4-dihydroxyphenyl)-2-propen-1-one Natural products OC1=CC(O)=CC=C1C=CC(=O)C1=CC=C(O)C=C1O ZWTDXYUDJYDHJR-UHFFFAOYSA-N 0.000 claims description 2
- 240000007440 Agaricus campestris Species 0.000 claims description 2
- 235000004570 Agaricus campestris Nutrition 0.000 claims description 2
- YQHMWTPYORBCMF-UHFFFAOYSA-N Naringenin chalcone Natural products C1=CC(O)=CC=C1C=CC(=O)C1=C(O)C=C(O)C=C1O YQHMWTPYORBCMF-UHFFFAOYSA-N 0.000 claims description 2
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 claims description 2
- 239000000284 extract Substances 0.000 claims description 2
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 claims description 2
- 229960004705 kojic acid Drugs 0.000 claims description 2
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 claims description 2
- GVALZJMUIHGIMD-UHFFFAOYSA-H magnesium phosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 claims description 2
- 239000004137 magnesium phosphate Substances 0.000 claims description 2
- 229960002261 magnesium phosphate Drugs 0.000 claims description 2
- 229910000157 magnesium phosphate Inorganic materials 0.000 claims description 2
- 235000010994 magnesium phosphates Nutrition 0.000 claims description 2
- 229930002330 retinoic acid Natural products 0.000 claims description 2
- 239000001488 sodium phosphate Substances 0.000 claims description 2
- 229910000162 sodium phosphate Inorganic materials 0.000 claims description 2
- 229960001727 tretinoin Drugs 0.000 claims description 2
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 claims description 2
- 239000011148 porous material Substances 0.000 abstract description 4
- 210000001124 body fluid Anatomy 0.000 abstract description 3
- 239000010839 body fluid Substances 0.000 abstract description 3
- 244000144725 Amygdalus communis Species 0.000 abstract 1
- 235000011437 Amygdalus communis Nutrition 0.000 abstract 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 abstract 1
- 239000008168 almond oil Substances 0.000 abstract 1
- 239000003921 oil Substances 0.000 description 17
- 239000002994 raw material Substances 0.000 description 7
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 230000003796 beauty Effects 0.000 description 4
- 239000000049 pigment Substances 0.000 description 4
- 230000036564 melanin content Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 208000008454 Hyperhidrosis Diseases 0.000 description 2
- SBLKVIQSIHEQOF-UPHRSURJSA-N Octadec-9-ene-1,18-dioic-acid Chemical compound OC(=O)CCCCCCC\C=C/CCCCCCCC(O)=O SBLKVIQSIHEQOF-UPHRSURJSA-N 0.000 description 2
- 206010039509 Scab Diseases 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- AFHJQYHRLPMKHU-GIWDNFATSA-N 1,8-dihydroxy-3-(hydroxymethyl)-10-[(3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-10h-anthracen-9-one Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)OC1C1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 AFHJQYHRLPMKHU-GIWDNFATSA-N 0.000 description 1
- 102100030310 5,6-dihydroxyindole-2-carboxylic acid oxidase Human genes 0.000 description 1
- 101710163881 5,6-dihydroxyindole-2-carboxylic acid oxidase Proteins 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 208000035985 Body Odor Diseases 0.000 description 1
- 206010055000 Bromhidrosis Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000218645 Cedrus Species 0.000 description 1
- 229920000832 Cutin Polymers 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 102100039094 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 240000003864 Ulex europaeus Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- CPUHNROBVJNNPW-UHFFFAOYSA-N aloin A Natural products OC1C(O)C(O)C(CO)OC1OC1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 CPUHNROBVJNNPW-UHFFFAOYSA-N 0.000 description 1
- 230000003255 anti-acne Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229940025250 camphora Drugs 0.000 description 1
- 239000010238 camphora Substances 0.000 description 1
- SVURIXNDRWRAFU-OGMFBOKVSA-N cedrol Chemical compound C1[C@]23[C@H](C)CC[C@H]3C(C)(C)[C@@H]1[C@@](O)(C)CC2 SVURIXNDRWRAFU-OGMFBOKVSA-N 0.000 description 1
- 229940026455 cedrol Drugs 0.000 description 1
- PCROEXHGMUJCDB-UHFFFAOYSA-N cedrol Natural products CC1CCC2C(C)(C)C3CC(C)(O)CC12C3 PCROEXHGMUJCDB-UHFFFAOYSA-N 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- VJNCICVKUHKIIV-UHFFFAOYSA-N dopachrome Chemical compound O=C1C(=O)C=C2NC(C(=O)O)CC2=C1 VJNCICVKUHKIIV-UHFFFAOYSA-N 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- SVURIXNDRWRAFU-UHFFFAOYSA-N juniperanol Natural products C1C23C(C)CCC3C(C)(C)C1C(O)(C)CC2 SVURIXNDRWRAFU-UHFFFAOYSA-N 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229940116918 octadecenedioic acid Drugs 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000003639 vasoconstrictive effect Effects 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
The invention discloses cypress essential oil bath salt which comprises the following components in parts by weight: 2-4 parts of cypress essential oil, 3-5 parts of lanolin alcohol sulphate sodium, 0.2-0.4 part of carboxymethyl inulin sodium and 100 parts of sodium chloride. By utilizing the sweet almond oil bath salt, dirt in human body pores can be eliminated, the body fluid equilibrium is kept, and the moisture loss is controlled.
Description
Technical field:
The present invention relates to a kind of bath salt, particularly a kind of cypress quintessence oil bath salt.
Background technology:
In the beauty treatment industry, use the salt beauty treatment that very long history has been arranged.The salt of beauty treatment usefulness adopts untreated crude salt mostly, because this salt particle is big, is unlikely to fast instantizing when smearing, and skin is had certain massage effect.Also because they do not pass through polish, the natural minerals composition is more, and is more beneficial to skin.It is strong that fine salt has a permeability, can deep layer dissolving dirt, and functions such as anti-acne.
Usually bath salt is become to be grouped into by medical herbs, natural sea salt, mineral and plants essential oil etc., be rich in the various trace elements such as ferrum, calcium, selenium, magnesium of needed by human body, the life-time service bath salt can be eliminated the melanin on the skin, allow skin recover tenderly white, soft, elasticity gradually, to dispeling facial skin sore, acne, mottle positive effect is arranged also.
The effect of bath salt is the permeability that utilizes salt, go deep into skin, impel blood circulation, enhance metabolism, take redundant moisture and fine material in the pore, fat etc. out of, play the effect of weight-reducing, utilize the scrub of salt, remove the cutin of skin surface, the skin that thirst smoothly comes off, delaying decrepitude of skin plays the effect of body building and beauty treatment.
The cypress quintessence oil, extraction: distill fresh leaf and cone, speciality: colourless or be extremely light yellow, charming succinum flavor as wooden and the face cream is arranged.Main component: obedient alkene, cedrol, Cedrus deoclar (Roxb.) G. Don Camphora, number acid and tannin.Attribute: rheumatism, antibiotic, spasmolytic, inhibition diaphoresis, convergence, promotion scab, except bromhidrosis, diuresis, bring down a fever, hemostasis, sharp liver, parasite killing, rehabilitation, calmness, astringing to arrest bleeding, benefit body, vasoconstrictive.English name: CYPRESS.Be suitable for skin: oiliness, aging hydropenia, corse sweat pore; Keep body fluid balance, the control water loss, quite helpful to the adult form skin, hyperhidrosis and oiliness skin are had regulating action; The function that promotion scabs is conducive to the healing of wound.
Yet existing commercially available prod does not have that particularly cypress quintessence oil and bath salt are composite with quintessence oil.
Summary of the invention:
At the prior art above shortcomings, technical problem to be solved by this invention provides a kind of cypress quintessence oil bath salt.
Technical problem of the present invention is achieved by following technical proposals:
A kind of cypress quintessence oil bath salt comprises following components by part by weight: 2-4 part cypress quintessence oil, 3-5 part lanolin alcohol polyethers sodium sulfovinate, 0.2-0.4 part carboxymethyl inulin sodium, 100 parts of sodium chloride.
Preferably,
A kind of cypress quintessence oil bath salt comprises following components by part by weight: 2-4 part cypress quintessence oil, 3-5 part lanolin alcohol polyethers sodium sulfovinate, 0.2-0.4 part carboxymethyl inulin sodium, 100 parts of sodium chloride, 0.05-0.15 part whitening agent.
Described whitening agent is a kind of or its mixture among Azelaic Acid, retinoic acid, phloretin, Agaricus campestris extract, Vc sodium phosphate, Vc magnesium phosphate, kojic acid, octadecene diacid, arbutin, barbaloin and the licochalcone A.
Optimum, described whitening agent is made of by weight following component: 10-30 part octadecene diacid, 10-30 part arbutin, 10-30 part barbaloin and 30-50 part licochalcone A.
Lanolin alcohol polyethers sodium sulfovinate, SODIUM LANETH SULFATE, CAS number: 68919-23-3.
Carboxymethyl inulin sodium, English name: Sodium carboxymethyl inulin, CAS No.430439-54-6.The concrete structure formula is as follows:
Octadecene diacid has another name called: octadecene diacid, English name: OCTADECENEDIOIC ACID, CAS accession number: 20701-68-2.Octadecene diacid what take off that black mechanism finds at present mainly is to stimulate Pexoxisome proliferator receptor (PPAR).After PPAR is combined, thereby the MRNA that can reduce tryrosinase expresses the black effect that presses down of playing.
Arbutin has another name called Arbutin, the acicular crystal that is white in color or powder.Extraction can be accelerated melanic decomposition and drainage from the leaf of Folium Vaccinii vitis-idaeae, thereby reduces the skin pigment deposition, and dispelling stain and freckle also have the effect of sterilization, antiinflammatory simultaneously.English name: Arbutin, CAS accession number: 497-76-7.
Barbaloin, CAS accession number: 5133-19-7, English name: Aloin claims again: 10-glucopyranosyl-1,8-dihydroxy-3-methylol-9 (10H)-anthrone.
Licochalcone A, English name: Licochalcone A, CAS accession number: 58749-22-7.Licochalcone A can restraint of tyrosinase, can suppress dopachrome interconvertible enzyme and DHICA oxidase again, also have significantly to remove free radical and antioxidation, and be a kind of additive of whitening cosmetics fast and efficiently.
If no special instructions, among the present invention related raw material all in working substance content 100%.Obviously can also add other raw materials in the present invention, as chelating agen, antibacterial, pigment, essence etc., other raw materials add basic its function separately that realizes, can not influence key property of the present invention usually.Those skilled in the art need not to pay creative work and can implement.
Cypress quintessence oil bath salt of the present invention can adopt industry universal method to be prepared from, and for example directly each component is mixed, and can make this cypress quintessence oil bath salt.
Cypress quintessence oil bath salt of the present invention has certain cleaning force, can remove human body pore dirt, keeps body fluid balance, the control water loss.Further, owing to added whitening agent, can eliminate the melanin on the skin, allow skin recover tenderly white gradually.
The specific embodiment:
Following embodiment further specifies of the present invention, rather than limits the scope of the invention.In the present invention, if no special instructions, each raw material is 100% in working substance content all.
Embodiment 1
Take by weighing: 3 kilograms of cypress quintessence oils, 4 kilograms of lanolin alcohol polyethers sodium sulfovinates, 0.3 kilogram of carboxymethyl inulin sodium, 100 kilograms of sodium chloride.Above-mentioned raw materials is at room temperature mixed, can make cypress quintessence oil bath salt of the present invention.
Embodiment 2-6
Embodiment 2-6 data by table 1 correspondence take by weighing each raw material respectively.Each raw material is at room temperature mixed, can make cypress quintessence oil bath salt of the present invention.
Table 1: bath salt formula table unit: kilogram
| ? | Embodiment 2 | Embodiment 3 | Embodiment 4 | Embodiment 5 | Embodiment 6 |
| The cypress quintessence oil | 3 | 3 | 3 | 3 | 3 |
| Lanolin alcohol polyethers sodium sulfovinate | 4 | 4 | 4 | 4 | 4 |
| Carboxymethyl inulin sodium | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 |
| Sodium chloride | 100 | 100 | 100 | 100 | 100 |
| Octadecene diacid | 0.02 | / | 0.02 | 0.02 | 0.06 |
| Arbutin | 0.02 | 0.04 | / | 0.02 | 0.02 |
| Barbaloin | 0.02 | 0.02 | 0.04 | / | 0.02 |
| Licochalcone A | 0.04 | 0.04 | 0.04 | 0.06 | / |
Test case:
25 volunteers are selected in experiment altogether, measure melanin content in the human body skin, and the white-skinned face function of bath salt product is estimated.
5 healthy people are selected in every group of test, age is in 18-40 year, sign Informed Consent Form with study subject, the MEXAMETE R MX18 skin pigment instrument that adopts German Courage+Khazaka company was using bath salt preceding 1 day and was using bath salt to measure the melanin content of skin outside its arm after 14 days continuously.Measure environment: test environment temperature (22 ± 1) ℃, humidity (50 ± 5) % averages.Study subject uses the bath salt product to take a shower every day, and bathing method is: put into 40 ℃ water in bathtub, and add 10 gram bath salts, study subject is taken a shower in bathtub.Study subject does not use other whitening products and cleaning product at test period.
This instrument of MEXAMETER MX18 skin pigment instrument is based on the principle (RGB) of spectral absorption, and the volume reflection of the illumination by measuring specific wavelength after on human body skin determined melanic content in the skin.The emitter of instrument probe sends rayed that wavelength is respectively 568nm, 660nm and three kinds of wavelength of 880nm at skin surface, and accepter records the light of skin reflex.Because radiative amount is certain, therefore just can measure by the amount of the light of skin absorbs, measure the content of dermal melanin.The measuring range of instrument is 0-999, and it is more high to measure numerical value, illustrates that melanin content is more high in the skin.
Table 2: test data table
The test data of experiment of associative list 2, can find out significantly: the present invention is initiatively with octadecene diacid, arbutin, barbaloin and the composite use of licochalcone A, for white-skinned face function, played obvious synergistic function, its mechanism remains the inventor and further studies.
Claims (4)
1. a cypress quintessence oil bath salt is characterized in that, comprises following components by part by weight: 2-4 part cypress quintessence oil, 3-5 part lanolin alcohol polyethers sodium sulfovinate, 0.2-0.4 part carboxymethyl inulin sodium, 100 parts of sodium chloride.
2. salt as claimed in claim 1 is characterized in that, comprises following components by part by weight: 2-4 part cypress quintessence oil, 3-5 part lanolin alcohol polyethers sodium sulfovinate, 0.2-0.4 part carboxymethyl inulin sodium, 100 parts of sodium chloride, 0.05-0.15 part whitening agent.
3. cypress quintessence oil bath salt as claimed in claim 2, it is characterized in that described whitening agent is a kind of or its mixture among Azelaic Acid, retinoic acid, phloretin, Agaricus campestris extract, Vc sodium phosphate, Vc magnesium phosphate, kojic acid, octadecene diacid, arbutin, barbaloin and the licochalcone A.
4. cypress quintessence oil bath salt as claimed in claim 3 is characterized in that described whitening agent is made of by weight following component: 10-30 part octadecene diacid, 10-30 part arbutin, 10-30 part barbaloin and 30-50 part licochalcone A.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310229539.XA CN103284926B (en) | 2013-06-08 | 2013-06-08 | Cypress essential oil bath salt |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310229539.XA CN103284926B (en) | 2013-06-08 | 2013-06-08 | Cypress essential oil bath salt |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103284926A true CN103284926A (en) | 2013-09-11 |
| CN103284926B CN103284926B (en) | 2014-11-05 |
Family
ID=49086825
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310229539.XA Expired - Fee Related CN103284926B (en) | 2013-06-08 | 2013-06-08 | Cypress essential oil bath salt |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103284926B (en) |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103845235A (en) * | 2014-02-13 | 2014-06-11 | 上海珍馨化工科技有限公司 | Whitening cosmetic |
| CN103845237A (en) * | 2014-02-13 | 2014-06-11 | 上海珍馨化工科技有限公司 | Whitening body lotion |
| CN103845234A (en) * | 2014-02-13 | 2014-06-11 | 上海珍馨化工科技有限公司 | Hyaluronic acid whitening cream |
| CN105232434A (en) * | 2015-11-24 | 2016-01-13 | 新会区会城美和商行 | Tea tree oil bath salt and preparing method thereof |
| CN105232433A (en) * | 2015-11-24 | 2016-01-13 | 新会区会城美和商行 | Bath salt and preparing method thereof |
| CN105232435A (en) * | 2015-11-24 | 2016-01-13 | 新会区会城美和商行 | Rosemary essential oil bath salt and preparation method |
| CN105267127A (en) * | 2015-11-24 | 2016-01-27 | 新会区会城美和商行 | Lemon essential oil bath salt and preparation method thereof |
| CN105287343A (en) * | 2015-11-24 | 2016-02-03 | 新会区会城美和商行 | Spearmint essential oil bath salt and making method thereof |
| CN105326748A (en) * | 2015-11-24 | 2016-02-17 | 新会区会城美和商行 | Peppermint essential oil bath salts and preparation method thereof |
| CN105326749A (en) * | 2015-11-24 | 2016-02-17 | 新会区会城美和商行 | Grapefruit essential oil bath salt and preparation method thereof |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6117509A (en) * | 1984-07-03 | 1986-01-25 | Yokoyama Mokuzai:Kk | Bath salts with hinoki smell |
| JP2000344659A (en) * | 1999-06-02 | 2000-12-12 | Masato Takeuchi | Bathing agent having microbicidal effect, deodorant effect and cleaning effect for hot water |
| WO2007077260A1 (en) * | 2006-01-05 | 2007-07-12 | Symrise Gmbh & Co. Kg | Formulations of low oil content comprising diphenylmethane derivatives |
| RU2307643C1 (en) * | 2006-05-06 | 2007-10-10 | Закрытое Акционерное Общество "Ресурс-Ф" | Method for balneal procedures in cardiovascular, respiratory, neurotic and skin diseases |
| CN101496775A (en) * | 2009-02-26 | 2009-08-05 | 徐伟玲 | Face cosmetic |
| CN102274147A (en) * | 2011-08-12 | 2011-12-14 | 河南城建学院 | Health-care bath salt and preparation method thereof |
| CN103025311A (en) * | 2010-05-25 | 2013-04-03 | 西姆莱斯有限公司 | Menthyl carbamate compounds as skin and/or hair lightening actives |
| CN103025310A (en) * | 2010-05-25 | 2013-04-03 | 西姆莱斯有限公司 | Cyclohexyl carbamate compounds as skin and/or hair lightening actives |
-
2013
- 2013-06-08 CN CN201310229539.XA patent/CN103284926B/en not_active Expired - Fee Related
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6117509A (en) * | 1984-07-03 | 1986-01-25 | Yokoyama Mokuzai:Kk | Bath salts with hinoki smell |
| JP2000344659A (en) * | 1999-06-02 | 2000-12-12 | Masato Takeuchi | Bathing agent having microbicidal effect, deodorant effect and cleaning effect for hot water |
| WO2007077260A1 (en) * | 2006-01-05 | 2007-07-12 | Symrise Gmbh & Co. Kg | Formulations of low oil content comprising diphenylmethane derivatives |
| RU2307643C1 (en) * | 2006-05-06 | 2007-10-10 | Закрытое Акционерное Общество "Ресурс-Ф" | Method for balneal procedures in cardiovascular, respiratory, neurotic and skin diseases |
| CN101496775A (en) * | 2009-02-26 | 2009-08-05 | 徐伟玲 | Face cosmetic |
| CN103025311A (en) * | 2010-05-25 | 2013-04-03 | 西姆莱斯有限公司 | Menthyl carbamate compounds as skin and/or hair lightening actives |
| CN103025310A (en) * | 2010-05-25 | 2013-04-03 | 西姆莱斯有限公司 | Cyclohexyl carbamate compounds as skin and/or hair lightening actives |
| CN102274147A (en) * | 2011-08-12 | 2011-12-14 | 河南城建学院 | Health-care bath salt and preparation method thereof |
Non-Patent Citations (4)
| Title |
|---|
| 卓绫: "《美少女不能不买的101件美容单品》", 31 January 2006, 上海文化出版社 * |
| 吕秀龄: "《养生养颜按摩手册》", 30 April 2010, article "背部浴盐", pages: 111 * |
| 吕秀龄: "《养生美颜按摩手册》", 30 April 2010, 吉林科学技术出版社 * |
| 洪文庆: "《女人与美容的对话》", 31 January 2002, 上海文艺出版社 * |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103845235A (en) * | 2014-02-13 | 2014-06-11 | 上海珍馨化工科技有限公司 | Whitening cosmetic |
| CN103845237A (en) * | 2014-02-13 | 2014-06-11 | 上海珍馨化工科技有限公司 | Whitening body lotion |
| CN103845234A (en) * | 2014-02-13 | 2014-06-11 | 上海珍馨化工科技有限公司 | Hyaluronic acid whitening cream |
| CN105232434A (en) * | 2015-11-24 | 2016-01-13 | 新会区会城美和商行 | Tea tree oil bath salt and preparing method thereof |
| CN105232433A (en) * | 2015-11-24 | 2016-01-13 | 新会区会城美和商行 | Bath salt and preparing method thereof |
| CN105232435A (en) * | 2015-11-24 | 2016-01-13 | 新会区会城美和商行 | Rosemary essential oil bath salt and preparation method |
| CN105267127A (en) * | 2015-11-24 | 2016-01-27 | 新会区会城美和商行 | Lemon essential oil bath salt and preparation method thereof |
| CN105287343A (en) * | 2015-11-24 | 2016-02-03 | 新会区会城美和商行 | Spearmint essential oil bath salt and making method thereof |
| CN105326748A (en) * | 2015-11-24 | 2016-02-17 | 新会区会城美和商行 | Peppermint essential oil bath salts and preparation method thereof |
| CN105326749A (en) * | 2015-11-24 | 2016-02-17 | 新会区会城美和商行 | Grapefruit essential oil bath salt and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103284926B (en) | 2014-11-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103284926B (en) | Cypress essential oil bath salt | |
| CN103284917B (en) | Rose essential oil bath salt | |
| CN103655353B (en) | Balm essential-oil bath salt | |
| CN103284924B (en) | Eucalyptus globulus oil bath salt | |
| CN103315923B (en) | Wheat germ oil bath salt | |
| CN103284921B (en) | Grapefruit oil bath salt | |
| CN103340774B (en) | Chamomile essential oil bath salt | |
| CN103340768B (en) | Peppermint oil bath salt | |
| CN103284922B (en) | Clove basil oil bath salt | |
| CN103284894B (en) | Sweet almond oil bath salt | |
| CN103315922B (en) | Jojoba oil bath salts | |
| CN103655350A (en) | Folium mugwort essential oil containing bath salt | |
| CN103284923B (en) | Lavender oil bath salt | |
| CN103284919B (en) | Tea tree oil bath salt | |
| CN103284925B (en) | Cananga odorata essential oil bath salt | |
| CN103340769B (en) | Pelargonium roseum oil bath salt | |
| CN103284920B (en) | Juniper berry essential oil bath salt | |
| CN103301036B (en) | Sweet orange oil-bath salt | |
| CN103655343A (en) | Osmanthus fragrans essential oil containing bath salt | |
| CN103340772B (en) | Rosewood essential-oil bath salt | |
| CN103655352A (en) | Eucalyptus oil bath salt | |
| CN103301037B (en) | Lemon oil bath salt | |
| CN103655344A (en) | Seabuckthorn seed oil containing bath salt | |
| CN103655351A (en) | Cinnamon essential oil containing bath salt | |
| CN103284918B (en) | Rosemary oil bath salt |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20180920 Address after: 244000 Tongling suburb industrial park in Anhui Patentee after: ANHUI TONGLING CITY TONGDOU SPECIAL CABLE CO.,LTD. Address before: 201604 219, room 2, Lane 1000, Tower Road, Shek Hu Town, Songjiang District, Shanghai Patentee before: SHANGHAI BAFANG FINE CHEMICAL ENGINEERING Co.,Ltd. |
|
| TR01 | Transfer of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20141105 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |